LP
CINC

LMR Partners’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

LMR Partners’s Portfolio CINC Stock Details CINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-22,914
Closed -$432K – 1332
2022
Q2 		$432K Sell
22,914
-7,488
-25% -$143K 0.01% 956
2022
Q1 		$533K Buy
+30,402
New +$624K 0.01% 963

Other funds holding CINC

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

LMR Partners's CINC Position: Q3 2022 in Review

LMR Partners sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q3 2022, closing a stake of 22,914 shares — an estimated $432K sold.

LMR Partners first reported a position in CINC in Q1 2022 and held it in 2 quarters. The position peaked at $533K in Q1 2022. 86 funds tracked by Wall St. Rank hold CINC as of Q3 2022.

  • LMR Partners reported no remaining CinCor Pharma, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • LMR Partners sold 22,914 CinCor Pharma, Inc. Common Stock shares in Q3 2022, an estimated $432K.
  • LMR Partners first reported a position in CinCor Pharma, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • LMR Partners's CinCor Pharma, Inc. Common Stock position peaked at $533K in Q1 2022.
  • 86 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q3 2022.

Based on LMR Partners's 13F filing for Q3 2022, filed 14 Nov 2022.